Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Multiple Allele Traits01:49

Multiple Allele Traits

38.0K
The Concept of Multiple Allelism
38.0K
Gene Therapy00:59

Gene Therapy

27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

5.3K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.3K
Multiple Regression01:25

Multiple Regression

3.8K
Multiple regression assesses a linear relationship between one response or dependent variable and two or more independent variables. It has many practical applications.
Farmers can use multiple regression to determine the crop yield based on more than one factor, such as water availability, fertilizer, soil properties, etc. Here, the crop yield is the response or dependent variable as it depends on the other independent variables. The analysis requires the construction of a scatter plot...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The total mass, copy number, and distribution of hormones in the human bloodstream.

PLoS biology·2026
Same author

Toward Solar-Powered Growth of Autotrophic <i>Escherichia coli</i> Using Photoelectrochemistry.

Journal of the American Chemical Society·2026
Same author

Nine changes needed to deliver a radical transformation in biodiversity measurement.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Synthetic cells by the numbers.

iScience·2025
Same author

Rubisco is slow across the tree of life.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

The global biomass of mammals since 1850.

Nature communications·2025
Same journal

Updated analysis of the Bronze Age population genetics from Bezdanjača Cave - the case of I2a1a male individuals.

Croatian medical journal·2026
Same journal

Systemic mesenchymal stem cell therapy for reduction of inflammatory burden in a patient with juvenile-onset rheumatoid arthritis and dialysis-dependent renal failure.

Croatian medical journal·2026
Same journal

Systemic metabolic, hormonal, and glycomic remodeling during a 72-hour fast in healthy adults: a pilot study.

Croatian medical journal·2026
Same journal

Artificial intelligence in pathology: a framework for preserving brain capital in the diagnostic apex.

Croatian medical journal·2026
Same journal

When algorithms testify: artificial intelligence-driven DNA analysis, evidentiary standards, and criminal justice reform.

Croatian medical journal·2026
Same journal

Artificial intelligence enables scale, consistency, and rigor in forensic identity inference.

Croatian medical journal·2026
See all related articles

Related Experiment Video

Updated: Jan 25, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.7K

Therapies for multiple sclerosis targeting B cells.

Ron Milo1

  • 1Ron Milo, Department of Neurology, Barzilai Medical Center, Ha-Histadrut St 2, Ashkelon 7308604, Israel, rmilo@bezeqint.net.

Croatian Medical Journal
|May 3, 2019
PubMed
Summary
This summary is machine-generated.

B cells play a critical role in multiple sclerosis (MS) pathogenesis through inflammation and immune cell activation. Therapies targeting B cells, like CD20-depleting monoclonal antibodies, show significant promise for managing MS.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.0K
A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
08:18

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

Published on: December 26, 2015

18.1K

Related Experiment Videos

Last Updated: Jan 25, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.7K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.0K
A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
08:18

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

Published on: December 26, 2015

18.1K

Area of Science:

  • Neuroimmunology
  • Immunopathology
  • Autoimmune Diseases

Background:

  • B cells are increasingly recognized for their dual role in regulating autoimmunity and driving immune-mediated diseases like multiple sclerosis (MS).
  • In MS, B cells adopt a pro-inflammatory phenotype, contributing to disease progression through antibody production, antigen presentation, and T cell activation.
  • Ectopic germinal centers in the meninges, driven by B cells, are linked to cortical pathology and neurological disability in MS.

Purpose of the Study:

  • To review the multifaceted role of B cells in the pathogenesis of multiple sclerosis (MS).
  • To discuss the therapeutic implications of targeting B cells and their associated pathways in MS treatment.
  • To highlight the impact of B cell-targeted therapies on MS clinical outcomes.

Main Methods:

  • Review of current scientific literature and clinical trial data on B cell involvement in MS.
  • Analysis of the mechanisms by which B cells contribute to MS pathology.
  • Evaluation of the efficacy and impact of B cell-targeting therapies, including monoclonal antibodies and kinase inhibitors.

Main Results:

  • B cells contribute to MS pathogenesis via antibody production, antigen presentation, T cell stimulation, and cytokine release.
  • CD20-targeting monoclonal antibodies (e.g., rituximab, ocrelizumab) have demonstrated significant anti-inflammatory effects and clinical benefits in relapsing and progressive MS.
  • Inhibition of Bruton's tyrosine kinase (BTK) is a promising therapeutic strategy, while targeting B cell cytokines has shown mixed results.

Conclusions:

  • B cells are key players in MS pathogenesis, making them a critical therapeutic target.
  • B cell-depleting therapies, particularly anti-CD20 monoclonal antibodies, are effective disease-modifying treatments for multiple sclerosis.
  • Further research is needed to fully elucidate the complex role of B cells and humoral immunity in MS to optimize therapeutic strategies.